Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to MYELOMA

The New England Journal of Medicine

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Hematology/Oncology January 2nd 2024

Hematology Advisor

Palliative Radiotherapy Linked to Pain Response in Multiple Myeloma

Hematology November 6th 2023

Clinical Oncology News

APHEXDA in Combination with Filgrastim Approved For Patients with Multiple Myeloma

Hematology/Oncology October 2nd 2023

OBR Oncology

BMS Accused by HMO of Patent Fraud to Allegedly Sustain Pomalyst Monopoly

Hematology/Oncology September 11th 2023

Myeloma Research News

Elranatamab, Now Elrexfio, Approved for Hard-to-treat Myeloma

Hematology/Oncology September 5th 2023

The New England Journal of Medicine

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

Hematology/Oncology September 5th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form